Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schiller

Showing results (11-20 of 284) with videos related to

Pageof 29
Sort By:
Canadian Journal of Biochemistry|January 1, 1977
Synthesis and solution conformation of [Trp1, Val5]-angiotensin IIP W Schiller
Progress in Medicinal Chemistry|January 1, 1991
Development of receptor-specific opioid peptide analoguesP W Schiller
International Journal of Peptide and Protein Research|March 1, 1983
Fluorescence study on the solution conformation to dynorphin in comparison of enkephalinP W Schiller
NIDA Research Monograph|January 1, 1991
Development of opioid peptide analogs as pharmacologic tools and as potential drugs: current status and future directionsP W Schiller
Life Sciences|March 17, 2009
Bi- or multifunctional opioid peptide drugsPeter W Schiller
Biophysical Chemistry|August 1, 1988
Role of the conformational element in peptide-receptor interactions. Studies with cyclic opioid peptide analogsP W Schiller
Canadian Journal of Biochemistry|May 1, 1979
Conformational comparison of (Val5, Trp8)-angiotensin II and (Val4, Trp7)-angiotensin III by fluorescence measurementsP W Schiller
Clearinghouse Review|February 1, 1975
Children in mental hospitalsWendy W Schiller
Biochemical and Biophysical Research Communications|July 18, 1983
Fluorescence study on the conformation of a cyclic enkephalin analog in aqueous solutionP W Schiller
Nature|May 6, 1982
Opiate receptor subclasses differ in their conformational requirementsP W Schiller, J DiMaio
Pageof 29

Showing results (11-20 of 284) with videos related to

Sort By:
Pageof 29
Canadian Journal of Biochemistry|January 1, 1977
Synthesis and solution conformation of [Trp1, Val5]-angiotensin IIP W Schiller
Progress in Medicinal Chemistry|January 1, 1991
Development of receptor-specific opioid peptide analoguesP W Schiller
International Journal of Peptide and Protein Research|March 1, 1983
Fluorescence study on the solution conformation to dynorphin in comparison of enkephalinP W Schiller
NIDA Research Monograph|January 1, 1991
Development of opioid peptide analogs as pharmacologic tools and as potential drugs: current status and future directionsP W Schiller
Life Sciences|March 17, 2009
Bi- or multifunctional opioid peptide drugsPeter W Schiller
Biophysical Chemistry|August 1, 1988
Role of the conformational element in peptide-receptor interactions. Studies with cyclic opioid peptide analogsP W Schiller
Canadian Journal of Biochemistry|May 1, 1979
Conformational comparison of (Val5, Trp8)-angiotensin II and (Val4, Trp7)-angiotensin III by fluorescence measurementsP W Schiller
Clearinghouse Review|February 1, 1975
Children in mental hospitalsWendy W Schiller
Biochemical and Biophysical Research Communications|July 18, 1983
Fluorescence study on the conformation of a cyclic enkephalin analog in aqueous solutionP W Schiller
Nature|May 6, 1982
Opiate receptor subclasses differ in their conformational requirementsP W Schiller, J DiMaio
Pageof 29